Hepatitis C in Black Adults: A Curable Disease You Can Miss

Hepatitis C is a bloodborne virus that scars the liver quietly over years, and it is curable. The CDC recommends that every adult get tested at least once. Most people with hepatitis C feel fine, which is exactly why the infection goes undiagnosed until the liver is already damaged. For Black adults, the stakes are higher: infection has historically been about twice as common as in other Americans, and deaths run well above the white rate. The fix is direct and well established. A simple blood test finds the virus, and a daily pill cures more than 95 percent of people in 8 to 12 weeks.

Hepatitis C virus (HCV) spreads through blood-to-blood contact. Once it reaches the liver, it triggers years of slow inflammation that builds scar tissue, a process called fibrosis that can progress to cirrhosis. Advanced cirrhosis raises the risk of liver failure and liver cancer, and hepatitis C is a leading driver of both in the United States. The damage is largely silent. The liver keeps working as it scars, so people feel nothing until it is far along.

About 2.4 million people in the US live with hepatitis C, and roughly three in four have no symptoms. When symptoms finally appear, they signal that damage is already advanced: persistent fatigue, yellowing of the eyes or skin (jaundice), dark urine, swelling in the abdomen or legs, and easy bruising. Waiting for symptoms is the worst screening strategy, because by then the window to prevent cirrhosis has narrowed.

The disparity is documented across decades of federal data. National surveys have found hepatitis C antibody positivity roughly twice as high among Black Americans as among the rest of the population, with the highest rates among Black men in their 40s. The mortality gap is just as stark. In the CDC's 2023 surveillance data, the hepatitis C death rate among non-Hispanic Black people was 1.7 times the rate among non-Hispanic white people.

The cruel part is that the gap is widest exactly where it should be smallest: getting cured. Direct-acting antivirals work the same regardless of race, yet Black patients are consistently less likely to receive them. In a 2025 study of hepatitis C care at an urban academic medical center from 2018 to 2023, Black patients had about 32 percent lower odds of starting antiviral treatment than white patients after adjusting for other factors. The authors found no clinical reason for the gap. It tracks with access, insurance hurdles, fewer trusted local providers, and stigma, not biology.

That same scarring pathway drives other liver disease in Black patients. If you are weighing your overall liver risk, our explainer on fatty liver disease in Black patients covers the metabolic side of the picture.

One large group was infected before anyone knew to look. Adults born from 1945 through 1965, the baby-boomer cohort, are about five times more likely to have hepatitis C than other adults. Many were exposed through blood transfusions or medical procedures before the blood supply was screened for HCV starting in 1992. They have often carried the virus for 30 or 40 years without knowing.

Injection drug use, including a single past episode, is the most common route today. But hepatitis C is not only a story about drug use, and treating it that way keeps people from getting tested. Transmission also happens through unregulated tattoos, shared personal items that carry blood, healthcare exposures, and birth from a parent with the virus. Roughly 45 percent of people who turn out to be infected do not recall any specific risk factor. That is why screening only people who look high-risk fails, and why the recommendation is now everyone.

In 2020 the CDC moved from risk-based testing to universal screening: every adult 18 and older should be tested for hepatitis C at least once, and pregnant people should be tested during each pregnancy. The US Preventive Services Task Force makes the same recommendation, which means insurers cover it without a copay in most plans.

The test is two steps from one blood draw. First, an antibody test (anti-HCV) shows whether you have ever been exposed to the virus. If that is reactive, the lab runs an HCV RNA test on the same sample to see whether the virus is still active in your body. A positive antibody with a positive RNA means a current infection that can be treated. A positive antibody with a negative RNA means past exposure that your body cleared, and no further action in most cases. Ask your clinician to run both at once so you are not waiting on a second visit for the answer that matters.

Hepatitis C is curable in more than 95 percent of cases with 8 to 12 weeks of direct-acting antiviral pills, usually one pill a day, with few side effects. "Cure" here is literal: the virus becomes undetectable and stays that way, which doctors call a sustained virologic response. A cure lowers the risk of liver cancer and liver failure, and it stops you from passing the virus to anyone else.

The barrier is rarely the medicine. It is getting to it. CDC data on insured adults found that even among people with diagnosed hepatitis C, only 23 percent on Medicaid, 28 percent on Medicare, and 35 percent with private insurance had started treatment within a year of diagnosis. Coverage rules that once demanded advanced liver scarring before approving the drugs have eased in most states, but prior-authorization paperwork, finding a clinician who treats hepatitis C, and stigma still cost lives. If a clinician tells you that you need to be sicker before you qualify, that is outdated. Today's guidelines recommend treatment for nearly everyone with the virus.

Ask for a one-time hepatitis C antibody test at your next appointment, and ask that the RNA test be run automatically if the antibody is reactive. Primary care clinicians can order it, and many can prescribe the cure themselves; others refer to a hepatologist or infectious-disease specialist. If you do not have a regular doctor, or want one who understands the communities we serve, use our directory to find a Black primary care clinician or hepatologist. While you are thinking about screening, a one-time test is also worth pairing with the other catch-it-early checks adults skip; see our guide to colon cancer screening for Black adults.